enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lilly's weight-loss drug removed from FDA's shortage list - AOL

   www.aol.com/news/us-fda-says-lillys-weight...

   Diabetes treatment Mounjaro has been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far outstripped supply. The limited ...

3. FDA warns companies over unapproved weight loss drug sales - AOL

   www.aol.com/news/fda-warns-companies-over...

   The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...

4. FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no ...

   www.aol.com/news/fda-weight-loss-drug-zepbound...

   The FDA said Novo Nordisk's semaglutide, which is sold as Ozempic to treat diabetes and Wegovy for weight loss, remains on the agency's drug shortage list even though all versions of the drug are ...

5. Off-brand versions of Lilly weight loss drug must be pulled ...

   www.aol.com/news/off-brand-versions-lilly-weight...

   "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said ...

6. US FDA warns online vendors selling unapproved weight-loss drugs

   www.aol.com/news/us-fda-warns-online-vendors...

   The agency also sent a warning letter to Veronvy, which offers unapproved and misbranded oral GLP-1 products, including one that claims to be approved by the FDA. US FDA warns online vendors ...

7. The Zepbound Shortage Is Over — Here's What to Expect ... - AOL

   www.aol.com/lifestyle/zepbound-shortage-over...

   Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...

8. Why compounders and telehealth providers are undeterred by ...

   www.aol.com/finance/why-compounders-telehealth...

   When the FDA announced Eli Lilly's active ingredient for diabetes drug Mounjaro and weight-loss drug Zepbound, tirzepatide, would be taken off the list on Oct. 2 after nearly two years, it began a ...

9. Compounding group sues FDA for removing Lilly's weight loss ...

   www.aol.com/news/compounding-group-sues-fda...

   (Reuters) -A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s blockbuster weight loss and diabetes drugs off its list of ...